Shandong Wohua Pharmaceutical Co Ltd (002107) — Tangible Net Worth Ratio
Shandong Wohua Pharmaceutical Co Ltd (002107) has a Tangible Net Worth Ratio of 95.2% as of December 2025. This metric is calculated by deducting intangible assets (CN¥34.34 Million) from net assets (CN¥720.90 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital to net assets of Shandong Wohua Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shandong Wohua Pharmaceutical Co Ltd Tangible Net Worth Ratio (2003–2025)
This chart shows how Shandong Wohua Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 23 annual periods from 2003 to 2025. As of December 2025, the ratio stands at 95.2%, reflecting net assets of CN¥720.90 Million with intangible assets of CN¥34.34 Million CNY. See Shandong Wohua Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Shandong Wohua Pharmaceutical Co Ltd from 2003 to 2025, covering 23 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 002107 market cap.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.2% | CN¥720.90 Million | CN¥34.34 Million | CN¥977.37 Million | ▲ +0.2 pp |
| 2024 | 95.1% | CN¥722.93 Million | CN¥35.56 Million | CN¥985.73 Million | ▼ -0.5 pp |
| 2023 | 95.6% | CN¥833.48 Million | CN¥36.84 Million | CN¥1.14 Billion | ▲ +0.1 pp |
| 2022 | 95.4% | CN¥789.79 Million | CN¥36.03 Million | CN¥1.10 Billion | ▲ +1.3 pp |
| 2021 | 94.1% | CN¥929.26 Million | CN¥54.80 Million | CN¥1.16 Billion | ▲ +0.2 pp |
| 2020 | 93.9% | CN¥918.01 Million | CN¥55.69 Million | CN¥1.37 Billion | ▼ -1.8 pp |
| 2019 | 95.8% | CN¥775.15 Million | CN¥32.79 Million | CN¥1.01 Billion | ▼ -1.3 pp |
| 2018 | 97.0% | CN¥695.78 Million | CN¥20.70 Million | CN¥922.38 Million | ▲ +1.6 pp |
| 2017 | 95.4% | CN¥655.78 Million | CN¥29.99 Million | CN¥855.50 Million | ▲ +4.7 pp |
| 2016 | 90.7% | CN¥572.64 Million | CN¥53.32 Million | CN¥705.63 Million | ▲ +1.4 pp |
| 2015 | 89.2% | CN¥547.26 Million | CN¥58.88 Million | CN¥668.23 Million | ▼ -0.2 pp |
| 2014 | 89.4% | CN¥631.74 Million | CN¥66.74 Million | CN¥668.64 Million | ▼ -1.0 pp |
| 2013 | 90.4% | CN¥605.04 Million | CN¥58.09 Million | CN¥645.05 Million | ▲ +1.0 pp |
| 2012 | 89.4% | CN¥594.41 Million | CN¥63.25 Million | CN¥643.70 Million | ▼ -8.2 pp |
| 2011 | 97.5% | CN¥586.07 Million | CN¥14.48 Million | CN¥622.35 Million | ▲ +1.6 pp |
| 2010 | 96.0% | CN¥590.64 Million | CN¥23.91 Million | CN¥636.14 Million | ▼ -0.4 pp |
| 2009 | 96.4% | CN¥688.45 Million | CN¥25.00 Million | CN¥773.86 Million | ▲ +1.8 pp |
| 2008 | 94.6% | CN¥637.88 Million | CN¥34.51 Million | CN¥712.11 Million | ▲ +5.0 pp |
| 2007 | 89.6% | CN¥342.22 Million | CN¥35.64 Million | CN¥452.54 Million | ▲ +2.4 pp |
| 2006 | 87.2% | CN¥142.57 Million | CN¥18.30 Million | CN¥237.01 Million | ▲ +4.1 pp |
| 2005 | 83.1% | CN¥111.06 Million | CN¥18.77 Million | CN¥194.94 Million | ▲ +6.4 pp |
| 2004 | 76.7% | CN¥82.62 Million | CN¥19.25 Million | CN¥152.92 Million | ▲ +14.3 pp |
| 2003 | 62.4% | CN¥51.69 Million | CN¥19.43 Million | CN¥134.97 Million | — |